Cargando…
Screening and Analysis of Possible Drugs Binding to PDGFRα: A Molecular Modeling Study
The platelet-derived growth factor receptor (PDGFR) is a membrane tyrosine kinase receptor involved in several metabolic pathways, not only physiological but also pathological, as in tumor progression, immune-mediated diseases, and viral diseases. Considering this macromolecule as a druggable target...
Autores principales: | Mozzicafreddo, Matteo, Benfaremo, Devis, Paolini, Chiara, Agarbati, Silvia, Svegliati Baroni, Silvia, Moroncini, Gianluca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253372/ https://www.ncbi.nlm.nih.gov/pubmed/37298573 http://dx.doi.org/10.3390/ijms24119623 |
Ejemplares similares
-
PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis
por: Paolini, Chiara, et al.
Publicado: (2022) -
Skin Gene Expression Profiles in Systemic Sclerosis: From Clinical Stratification to Precision Medicine
por: Benfaremo, Devis, et al.
Publicado: (2023) -
Systemic Sclerosis: From Pathophysiology to Novel Therapeutic Approaches
por: Benfaremo, Devis, et al.
Publicado: (2022) -
Increased expression of the ectoenzyme CD38 in peripheral blood plasmablasts and plasma cells of patients with systemic sclerosis
por: Agarbati, S., et al.
Publicado: (2022) -
Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice
por: Moroncini, Gianluca, et al.
Publicado: (2018)